This clinical trial is focused on studying a condition known as complicated acute appendicitis in children. This condition occurs when the appendix, a small organ attached to the large intestine, becomes severely inflamed and infected, often requiring surgical removal. The study aims to evaluate a new treatment approach called the “Fast Track” strategy, which is designed to help children recover more quickly after surgery and potentially shorten their hospital stay.

The treatment being tested involves the use of medications containing amoxicillin and clavulanic acid. These are antibiotics that help fight infections by killing bacteria or preventing their growth. In this study, these medications are given in two forms: a solution for injection or infusion, and film-coated tablets. The trial will compare this new approach to the standard treatment to see if it is just as effective in preventing complications after surgery, such as infections or other issues that might require further medical attention.

Participants in the study will undergo a surgical procedure called a laparoscopic appendectomy, which is a minimally invasive surgery to remove the appendix. After the surgery, they will receive the study treatment and be monitored for any adverse events, such as infections or complications, for 30 days. The goal is to determine if the Fast Track strategy can safely reduce the length of hospital stays without increasing the risk of complications. This study is important for improving recovery times and overall outcomes for children with complicated acute appendicitis.